Clinical nutrition is a broad subject that uses food characteristics and adjusts body metabolism under pathological conditions to relieve symptoms, promote rehabilitation, and improve the quality of life after healing. The dietary nutrition measures taken based on the principles of nutrition are called therapeutic diets, which are divided into therapeutic diets and experimental diets according to their functions. Clinical nutrition is the prevention and treatment of nutritional deficiencies. Clinical nutrition should include enteral nutrition (nutrition meals, patient diet management), parenteral nutrition (intravenous nutrition), and nutrition clinic.
The global clinical nutrition market size was valued around USD 56.03 Billion in 2019 and projected to generate USD 100.88 Billion by 2027, registering a CAGR of 7.29%, during the forecast period, 2020-2027. The growth of the market can be attributed to the rise in the number of people suffering from chronic diseases such as cancer and diabetes, along with the growing geriatric population base. Further, the ever-increasing geriatric and aging population, mostly in the developed economies, will spur the growth of the market. Additionally, the surge in the prevalence of metabolic disorders, high spending on healthcare, and the augmentation of the middle class are anticipated to boost the global clinical nutrition market share. Also, the higher birth rate, the increasing number of malnutrition victims receiving treatment, and a higher number of premature births expected to foster the growth of the market.
Moreover, the growing obese population as a result of unhealthy dietary habits and physical inactivity will drive the clinical nutrition industry. Furthermore, the improved healthcare system, coupled with the high rate of birth in developing nations, will fuel the growth of the global clinical nutrition industry. Also, the rising prevalence of metabolic diseases and increases healthcare spending across emerging nations are strengthening market growth. The upsurge in the prevalence of chronic disorders and the rise in the number of patients using the advanced clinical nutritional product will impact the growth of the global clinical nutrition market in the upcoming periods. Additionally, the growing usage of clinical nutrition to provide a sufficient amount of nutrients such as vitamins, protein, and minerals to the patients and helps to keep energy balance is positively impacting the demand.
Metabolic disorders are directly related to cardiovascular diseases such as congenital heart disease, macrovascular disease, arrhythmia, heart failure, and ischemic heart disease. Glucose metabolism disorder, lipid metabolism disorder, and amino acid metabolism disorder will all aggravate cardiovascular disease death. The metabolism is regulated by genetics, neurohumor, hormones, enzymes, liver, and other tissues and organs. When these factors are abnormal, it can cause lipid metabolism disorders and pathophysiological changes associated with organs, such as hyperlipoproteinemia, lipid storage diseases resulting in clinical syndrome, obesity, ketosis acidosis, fatty liver, and neonatal scleroderma.
According to the United Nations, the world’s population will reach 11 billion by the end of this century, and 2 billion people will be added in the next 30 years. Further, the global population would increase by 2 billion people in the next 30 years, from 7.7 billion in 2019 to 9.7 billion in 2050. By the end of this century, the global population will continue to grow to about 11 billion.
According to WHO, every year, an estimated 15 million babies are born preterm, and approximately 1 million children die each year due to complications of preterm birth. These factors will enhance the demand for clinical nutrition in developing nations and under developing countries to survive the life of the newborn baby.
Recently outbreak pandemic, COVID-19, a disease caused by a novel coronavirus that mainly targets the human respiratory system. In this situation, proper nutrition and hydration are vital. WHO advised eating a variety of fresh and unprocessed foods every day to get the vitamins, minerals, dietary fiber, protein, and antioxidants body needs. These respiratory diseases are mainly affecting the old age population and newborn baby. These factors will influence the global clinical nutrition market.
Based on the product, the global clinical nutrition market classified into Infant Nutrition (Milk, Soy, and Organic), Parenteral Nutrition (Amino Acids, Fats, and Carbohydrates), Enteral Nutrition (Standard Composition, Disease-Specific Composition). The infant nutrition dominated the global market in 2019 and is projected to expand with a higher CAGR through the forecast period. It is primarily attributed to the surge in the number of premature births and malnourished babies, along with increasing awareness camps by domestic governments about infant nutritional products.
Parenteral Nutrition will grow with a significant rate in the estimated period due to the surge in the number of people who have cancer, ischemic bowel disease, and Crohn’s disease for which they require an external supply of nutrients.
Based on the application, the global clinical nutrition market segregated into cancer, neurological disease, gastrointestinal disorders, metabolic disorders, and others. The cancer segment held a lucrative share in 2019 and likely to dominate the global clinical nutrition market by 2027. It is due to the rise in the number of cancer affected patients along with nutritional deficiency that arises in patients as of various cancer treatments such as chemotherapy, hormone therapy, etc.
The metabolic disorders will grow at a substantial CAGR in the forecast period. It is owing to the rise in the number of heart disease patients and blood pressure patients around the world.
Based on end-user, the global clinical nutrition market segmented into a pediatric, adult, and geriatric. The pediatric segment estimated to lead the market by 2027 due to the increasing number of preterm births coupled with growing awareness about clinical nutritional products.
The adult segment will grow with a significant rate during the forecast period owing to the growing patient population suffering from chronic conditions, and the surge in consumption of junk food leads to scarcity of essential nutrients by this age group.
Based on geography, the global clinical nutrition market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominated the industry in 2019 and will capture the highest CAGR by 2027. It is owing to a hectic lifestyle and unhealthy dietary habits leading to a large number of people suffering from chronic diseases such as obesity and diabetes.
The Asia Pacific will be the fastest-growing segment during the forecast span due to the rise in metabolic disorders, high disposable incomes, and improvement in growing among patients regarding the benefits of clinical nutrition products.
Companies such as Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Danone, Fresenius Kabi, Hospira, Mead Johnson, Perrigo, Nestle Nutrition, Ajinomoto Co. Inc, Lonza Ltd, Gentiva Health Services Inc., Kendall, Hero Nutritionals Inc., American Home Patient Inc., H. J. Heinz Company are the key players in the global clinical nutrition market.